Cargando…

Vitamin C promotes the proliferation and effector functions of human γδ T cells

γδ T cells are of interest as effector cells for cellular immunotherapy due to their HLA-non-restricted lysis of many different tumor cell types. Potential applications include the adoptive transfer of in vitro-expanded γδ T cells. Therefore, it is important to optimize the culture conditions to ena...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kouakanou, Léonce, Xu, Yan, Peters, Christian, He, Junyi, Wu, Yangzhe, Yin, Zhinan, Kabelitz, Dieter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192840/ https://www.ncbi.nlm.nih.gov/pubmed/31171862 http://dx.doi.org/10.1038/s41423-019-0247-8

Ejemplares similares

Reply to: Vitamin C as a promoter of γδ T cells
por: Kouakanou, Léonce, et al.
Publicado: (2021)

Vitamin C supports conversion of human γδ T cells into FOXP3-expressing regulatory cells by epigenetic regulation
por: Kouakanou, Léonce, et al.
Publicado: (2020)

Cancer immunotherapy with γδ T cells: many paths ahead of us
por: Kabelitz, Dieter, et al.
Publicado: (2020)

Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us
por: Kabelitz, Dieter, et al.
Publicado: (2020)

Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?
por: Bhat, Jaydeep, et al.
Publicado: (2018)

Vitamin C, From Supplement to Treatment: A Re-Emerging Adjunct for Cancer Immunotherapy?
por: Kouakanou, Léonce, et al.
Publicado: (2021)

Vitamin C and Vitamin D—friends or foes in modulating γδ T-cell differentiation?
por: Peters, Christian, et al.
Publicado: (2022)

γδ T cells: origin and fate, subsets, diseases and immunotherapy
por: Hu, Yi, et al.
Publicado: (2023)

Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer
por: Xu, Yan, et al.
Publicado: (2020)

Analysis of the Seasonal Fluctuation of γδ T Cells and Its Potential Relation with Vitamin D(3)
por: Bernicke, Birthe, et al.
Publicado: (2022)

Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells
por: Peters, Christian, et al.
Publicado: (2013)

Hepatocellular carcinoma‐infiltrating γδ T cells are functionally defected and allogenic Vδ2(+) γδ T cell can be a promising complement
por: He, Wenjing, et al.
Publicado: (2022)

Human γδ T lymphocytes for immunotherapeutic strategies against cancer
por: Kabelitz, Dieter
Publicado: (2010)

Gamma Delta T Cells (γδ T Cells) in Health and Disease: In Memory of Professor Wendy Havran
por: Kabelitz, Dieter
Publicado: (2020)

Immunosurveillance by human γδ T lymphocytes: the emerging role of butyrophilins
por: Kabelitz, Dieter, et al.
Publicado: (2017)

Apoptosis, Pyroptosis, and Ferroptosis Conspiringly Induce Immunosuppressive Hepatocellular Carcinoma Microenvironment and γδ T-Cell Imbalance
por: Hu, Yi, et al.
Publicado: (2022)

Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy
por: Oberg, Hans-Heinrich, et al.
Publicado: (2014)

Monocyte-dependent co-stimulation of cytokine induction in human γδ T cells by TLR8 RNA ligands
por: Serrano, Ruben, et al.
Publicado: (2021)

Editorial: γδ T Cells in Cancer
por: Coffelt, Seth B., et al.
Publicado: (2020)

Galectin-3 Released by Pancreatic Ductal Adenocarcinoma Suppresses γδ T Cell Proliferation but Not Their Cytotoxicity
por: Gonnermann, Daniel, et al.
Publicado: (2020)

The Vγ4/butyrophilin conspiracy: novel role of intraepithelial γδ T cells in chronic inflammatory bowel disease
por: Kabelitz, Dieter
Publicado: (2023)

Editorial: Next generation γδ T cell-based tumor immunotherapy
por: Tan, Andy Hee-Meng, et al.
Publicado: (2022)

Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes
por: Serrano, Ruben, et al.
Publicado: (2020)

Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells
por: Jonescheit, Hannah, et al.
Publicado: (2020)

γδ T Lymphocytes: An Effector Cell in Autoimmunity and Infection
por: Shiromizu, Carolina Maiumi, et al.
Publicado: (2018)

Regulation of γδ T Cell Effector Diversification in the Thymus
por: Parker, Morgan E., et al.
Publicado: (2020)

Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity
por: Kabelitz, Dieter, et al.
Publicado: (2013)

γδT cells are ADCC effectors in elite HIV controllers
por: Poonia, Bhawna, et al.
Publicado: (2010)

Differential metabolic requirement governed by transcription factor c-Maf dictates innate γδT17 effector functionality in mice and humans
por: Chen, Xu, et al.
Publicado: (2022)

Correction: Serrano, R.; Wesch, D.; Kabelitz, D. Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes. Cells 2020, 9, 713
por: Serrano, Ruben, et al.
Publicado: (2020)

γδ T cells recruitment and local proliferation in brain parenchyma benefit anti-neuroinflammation after cerebral microbleeds
por: Su, Xin, et al.
Publicado: (2023)

Human Breast Milk: From Food to Active Immune Response With Disease Protection in Infants and Mothers
por: Lokossou, Gatien A. G., et al.
Publicado: (2022)

TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells
por: Tawfik, Doaa, et al.
Publicado: (2019)

The human fetal thymus generates invariant effector γδ T cells
por: Tieppo, Paola, et al.
Publicado: (2019)

Metabolites in the Tumor Microenvironment Reprogram Functions of Immune Effector Cells Through Epigenetic Modifications
por: Li, Yijia, et al.
Publicado: (2021)

4‐1BB and cytokines trigger human NK, γδ T, and CD8(+) T cell proliferation and activation, but are not required for their effector functions
por: Vidard, Laurent
Publicado: (2022)

Intrathymic programming of effector fates in three molecularly distinct γδ T cell subtypes
por: Narayan, Kavitha, et al.
Publicado: (2012)

From thymus to periphery: Molecular basis of effector γδ‐T cell differentiation
por: Fiala, Gina J., et al.
Publicado: (2020)

γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
por: de Vries, Natasja L., et al.
Publicado: (2023)

Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation
por: Song, Yuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_puahhq962bko9pvq49masnijkn